There is limited known legitimate manufacture of and trade in 4-piperidone and 1-boc-4-piperidone. The scheduling of those substances in Category 1 would consequently entail limited additional administrative burden for economic operators and for the competent authorities in the Union.
Recital 10, Regulation (EU) 2025/1475
In forcesince 21 May 2025